US Government Suspends Free At-Home COVID-19 Antigen Test Program
Biden administration blames the decision on Congress’ failure to provide the additional funding necessary to keep the program going.
News-nir
Subscribe today for access to
Articles and Reports
CMS Ignores Flawed Processes, Finalizes 2018 PAMA Pricing; Labs Need to Take Immediate Action to Offset Impending Lean Times
By Kyle Fetter bio
The final 2018 clinical laboratory fee schedule (CLFS) is out, and it is evident that the argument that the Centers for Medicare & Medicaid Services (CMS) PAMA process was…
Millennium Labs Bankruptcy Plan Stays on Track despite Lender Opposition
From - National Intelligence Report
It has been nearly two years since Millennium went into Chapter 11 but the case continues to make news. After agreeing to…
Are Labs Personally Liable to Data Breach Victims—CareFirst Case May Provide the Answer
From - National Intelligence Report
While data breaches inside labs and other health care settings happen all the time, lawsuits for money damages by victims have been relatively unusual…
OPPS 2018: Revised Payment Rates & a New ADLT Date of Service Exemption
...
Already a member? Log in here
FDA Watch: Agency Moves to Boost CLIA Waiver Transparency
From - National Intelligence Report
The CLIA standards that a lab must meet are based on the complexity of the in vitro diagnostic tests it…
Employment Law Update: The Weinstein Edition
By Mike O'Brien bio
Your news feed, like mine, has exploded with references to someone named Harvey Weinstein for the past few weeks. What's up? Weinstein is…
EHR: Window Closes on Meaningful Use Exemptions as Congress Seeks to Make Future Compliance Easier
From - National Intelligence Report
October has been a big month for meaningful use compliance…